Orthofix Lowers Full-Year Outlook Due to Medicare Reimbursement Changes

Shares of Orthofix Medical (OFIX) dropped approximately 8% in premarket trading after the company cut its full-year outlook, citing changes in Medicare reimbursements affecting its non-invasive bone growth stimulators. The orthopedic device maker now expects lower financial performance for the year.

By Dulan Lokuwithana, SA News Editor · Seeking Alpha · May 21, 2026, 12:46 UTC

Orthofix Lowers Full-Year Outlook Due to Medicare Reimbursement Changes

Tickers: $OFIX

Topics: Medicare reimbursement changes Orthofix Medical Stock price drop

Read the full article at Seeking Alpha

More World news

Nebius Group Reports Massive Q3 2026 Revenue Growth Driven by AI Cloud Expansion Motley Fool · November 12, 2026, 17:29 UTC
Reagan Institute Launches Society of Fellows to Support Early Career Scholars PR Newswire · November 12, 2026, 17:32 UTC
Global Asset Management Group Signs LOI for $100 Million Affordable Housing Portfolio in Washington, D.C. PR Newswire · November 12, 2026, 17:30 UTC
U.S. Air Conditioner and Heat Pump Shipments Increase 27.3% in September Seeking Alpha · November 12, 2026, 17:27 UTC
Nvidia CEO Jensen Huang Resigns Amid Intelligence Probe Seeking Alpha · November 12, 2026, 17:27 UTC
Oklo and Centrus Energy Sign Multi-Year HALEU Fuel Supply Agreements for Ohio Nuclear Campus Seeking Alpha · November 12, 2026, 17:28 UTC
IRS Announces Increased 401(k) Contribution Limits for 2027 CNBC · November 12, 2026, 17:23 UTC
Bit Digital Announces $865 Million Contract and Commencement of 40MW Billing Seeking Alpha · November 12, 2026, 17:20 UTC
Nvidia CEO Jensen Huang Resigns Amid Investigation and Personal Allegations Motley Fool · November 12, 2026, 17:20 UTC
Argus Research Upgrades Republic Services to Buy Seeking Alpha · November 12, 2026, 17:16 UTC